267 related articles for article (PubMed ID: 8748261)
1. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.
Aguero-Rosenfeld ME; Nowakowski J; Bittker S; Cooper D; Nadelman RB; Wormser GP
J Clin Microbiol; 1996 Jan; 34(1):1-9. PubMed ID: 8748261
[TBL] [Abstract][Full Text] [Related]
2. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease.
Engstrom SM; Shoop E; Johnson RC
J Clin Microbiol; 1995 Feb; 33(2):419-27. PubMed ID: 7714202
[TBL] [Abstract][Full Text] [Related]
3. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis.
Hammers-Berggren S; Lebech AM; Karlsson M; Svenungsson B; Hansen K; Stiernstedt G
J Clin Microbiol; 1994 Jun; 32(6):1519-25. PubMed ID: 8077398
[TBL] [Abstract][Full Text] [Related]
4. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of serologic tests for lyme disease.
Steere AC; McHugh G; Damle N; Sikand VK
Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
[TBL] [Abstract][Full Text] [Related]
7. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
Glatz M; Golestani M; Kerl H; Müllegger RR
Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
[TBL] [Abstract][Full Text] [Related]
9. Persistent Anti-
Markowicz M; Reiter M; Gamper J; Stanek G; Stockinger H
Microbiol Spectr; 2021 Dec; 9(3):e0102021. PubMed ID: 34937165
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease.
Rauer S; Spohn N; Rasiah C; Neubert U; Vogt A
J Clin Microbiol; 1998 Apr; 36(4):857-61. PubMed ID: 9542898
[TBL] [Abstract][Full Text] [Related]
11. Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migrans.
Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Rymaszewska A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
Ann Agric Environ Med; 2007; 14(2):209-13. PubMed ID: 18247452
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
[TBL] [Abstract][Full Text] [Related]
13. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans.
Glatz M; Fingerle V; Wilske B; Ambros-Rudolph C; Kerl H; Müllegger RR
Dermatology; 2008; 216(2):93-103. PubMed ID: 18216470
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
Christova I
Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
[TBL] [Abstract][Full Text] [Related]
15. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
[TBL] [Abstract][Full Text] [Related]
17. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I
J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063
[TBL] [Abstract][Full Text] [Related]
18. Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans.
Mitchell PD; Reed KD; Aspeslet TL; Vandermause MF; Melski JW
J Clin Microbiol; 1994 Aug; 32(8):1958-62. PubMed ID: 7989549
[TBL] [Abstract][Full Text] [Related]
19. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol.
Ledue TB; Collins MF; Craig WY
J Clin Microbiol; 1996 Oct; 34(10):2343-50. PubMed ID: 8880477
[TBL] [Abstract][Full Text] [Related]
20. Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.
Marangoni A; Moroni A; Accardo S; Cevenini R
Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):349-54. PubMed ID: 18197445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
